Author Archive: Abigail Hirsch

Abigail Hirsch

Abigail is the Director of Events Communications at BIO. Although she has lived in the Washington, DC, area for nearly eight years, she still considers Virginia Beach home, especially with her parents and closest friends still in the area. According to Abigail, there is nothing better than sitting on the beach with a good book and cold drink. In her spare time, she enjoys visiting antique stores, finishing her twin sister Brooke’s sentences and spending time with her two boys, Frank her English bulldog, and JP her soon-to-be husband. Check back often for updates, Abigail’s take on BIO related events, and much more. And please, be kind, this is her first venture in to the blogging world!

Latest Posts

BIO to Host Google+ Hangout with David Brancaccio

BIOORG-Campaign-GooglePlus

Join us for a preview discussion with David Brancaccio, host of American Public Media’s Marketplace Morning Report and Scientific American Worldview editors on March 25, 11AM-12PM, as we explore the main themes of this year’s Scorecard edition – The Cost & Benefits of Innovation. Editors will also discuss: Innovation’s true “value proposition” and the ways in which investing in science has multilayered societal returns; The biggest issues in biotech that continue to “flatten” the world and create common missions among countries; Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

#BIOCEO14: An Optimistic Outlook for 2014

Panel

The 16th Annual BIO CEO & Investor Conference​ concluded with a lively Closing Plenary Session examining the current capital market for IPOs, where the industry has been and where it’s headed in 2014. The panel unanimously agreed: 2013 was the year of the IPO. In total, 56 healthcare companies priced an IPO; 43 of these were biotech companies. Last year was the strongest IPO year since 2000 and the second strongest in history with over $10 Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Fireside Chat with Allergan CEO, David Pyott

David Pyott

Day two of the 16th Annual BIO CEO & Investor Conference​ kicked off with a Fireside Chat featuring one of the longest tenured pharma CEOs, David E.I. Pyott, Chairman of the Board & Chief Executive Officer, Allergan. The Chat, moderated by Seamus Fernandez, Managing Director, Major and Specialty Pharmaceuticals, Leerink Partners LLC, explored the multi-specialty healthcare model that Allegran has found success in which few realize is not just ophthalmology. Allergan has also found success in neurosciences, medical dermatology, dermal fillers and urologics. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

More than a Quarter of 2013 US-Based Biotech IPOs Call California Home

BIO CONVENTION LOGO_VERTICAL_D_CMYK

And of those 39 US-based biotech companies, five of them are from San Diego, highlighting the region’s growing importance as hub for the biotech and life science industries. According to a recently authored BIO article in the Union Tribune San Diego, there are several reasons at play for the strong public offerings – enactment of the JOBS Act, an eager investor market and increasing regulatory transparency resulting from PDUFA V. As powerful as the JOBS Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Bioscience’s Bright Spots

2014_BIO

According to Business Xpansion Journal, biotech is still big business and partnerships lead to profit. And BIO agrees. “In the past several years, it has become more important than ever for those in our industry to form partnerships and collaborations,” says Fritz Bittenbender, executive vice president, external affairs, BIO. “Big pharma, small biotechs, universities, investors, patient groups, the NIH – everyone is recognizing that success is only achieved by working with others. One place we’ve seen this Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,